Výsledky vyhledávání

Calcipotriol plus betamethasone dipropionate aerosol foam provides superior efficacy vs. gel in patients with psoriasis vulgaris: randomized, controlled PSO‐ABLE study

Autor: L. Stein Gold, Frédéric Cambazard, Robert E. Kalb, Bo Bang, Carle Paul, Christopher E.M. Griffiths, David Lowson

Publikováno v: Journal of the European Academy of Dermatology and Venereology
Paul, C, Stein Gold, L, Cambazard, F, Kalb, R E, Lowson, D, Bang, B & Griffiths, C E M 2016, ' Calcipotriol plus betamethasone dipropionate aerosol foam provides superior efficacy vs. gel in patients with psoriasis vulgaris : randomized, controlled PSO-ABLE study ', Journal of the European Academy of Dermatology and Venereology : JEADV . https://doi.org/10.1111/jdv.13859

BACKGROUND: Fixed combination calcipotriol 50 μg/g (Cal) plus betamethasone 0.5 mg/g (BD) foam has been developed as a new treatment option for patients with psoriasis.METHODS: The randomized, parallel-group, investigator-blinded Phase III, 12-week

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4beb25402f7f9b4b064a27de7b069d0e
http://europepmc.org/articles/PMC6207928

Zobrazit plný text záznamu

A seamless phase I/II dose-finding trial assessing ingenol disoxate (LEO 43204) for field treatment of actinic keratosis on the scalp

Autor: Bo Bang, C.W. Hanke, J. Weiss, M. Bukhalo, M.L. Østerdal, M. Ulrich

Publikováno v: The British journal of dermatology. 176(6)

BACKGROUND Actinic keratosis (AK) is a common sun-related skin condition, which can progress to squamous cell carcinoma and occur in cancerized fields. OBJECTIVES To investigate in a phase I/II trial the safety and efficacy of ingenol disoxate as top

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69f96dc70108f6b4830cef33a9d8e7f1
https://pubmed.ncbi.nlm.nih.gov/28581227

Zobrazit plný text záznamu

Fixed combination calcipotriol plus betamethasone dipropionate aerosol foam in the treatment of psoriasis vulgaris: rationale for development and clinical profile

Autor: Bo Bang, Carle Paul, Mark Lebwohl

Publikováno v: Expert opinion on pharmacotherapy. 18(1)

Psoriasis is a chronic, immune-mediated inflammatory disorder with a significant negative impact on quality of life. Most patients with mild-to-moderate psoriasis manage their disease with topical therapies; the most commonly used formulations contai

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e9b4053dd952b93d3510ad6b7f5391f
https://pubmed.ncbi.nlm.nih.gov/27936972

Zobrazit plný text záznamu

Favourable results of Mohs micrographic surgery for basal cell carcinoma

Autor: Robert, Gniadecki, Martin, Glud, Kia, Mortensen, Bo, Bang, Edyta, Biskup, Silje Haukali, Omland

Publikováno v: Danish medical journal. 62(12)

Basal cell carcinoma (BCC) is the most common malignant neoplasm with an annual incidence approaching 200/100,000 person-years. Mohs micrographic surgery (MMS) is widely used in North America and in Europe for treatment of BCC. This technique ensures

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::acbbd1e34d8ff0f86e95340f216e663e
https://pubmed.ncbi.nlm.nih.gov/26621396

Zobrazit plný text záznamu

Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma

Autor: Martin Gramatzki, Franck Morschhauser, Thomas Relander, Hervé Tilly, John Radford, Anders Österborg, Francesco d'Amore, Martin Dreyling, Mats Jerkeman, Bo Bang, Hans Hagberg

Publikováno v: British Journal of Haematology. 150:565-573

The efficacy and safety of zanolimumab (HuMax-CD4) in patients with relapsed or refractory peripheral T Cell lymphoma (PTCL) was evaluated. Twenty-one adult patients with relapsed or refractory CD4(+) PTCL of non-cutaneous type (angioimmunoblastic T

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::04da8f4528c79862b1ef8c43dfc925d4
https://doi.org/10.1111/j.1365-2141.2010.08298.x

Zobrazit plný text záznamu

Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris

Autor: Bo Bang, Stine Lasthein, Lars Iversen, L.E. Bryld, Robert Gniadecki, Lone Skov

Publikováno v: Gniadecki, R, Bang, B, Bryld, L E, Iversen, L, Lasthein, S & Skov, L 2015, ' Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris ', British Journal of Dermatology, vol. 172, no. 1, pp. 244-52 . https://doi.org/10.1111/bjd.13343
Gniadecki, R, Bang, B, Bryld, L E, Iversen, L, Lasthein, S & Skov, L 2015, ' Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris ', British Journal of Dermatology, vol. 172, no. 1, pp. 244-252 . https://doi.org/10.1111/bjd.13343

BACKGROUND: Drug survival (time to drug discontinuation) has recently emerged as an important parameter reflecting the long-term therapeutic performance in a real-life setting. Biologic drug survival in psoriasis is mainly limited by a gradual loss o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fdca163fbb7bb92eea3d9c1ae184c0a
https://pure.au.dk/portal/da/publications/comparison-of-longterm-drug-survival-and-safety-of-biologic-agents-in-patients-with-psoriasis-vulgaris(7a2dd816-3923-40b3-8331-4e78d0189c30).html

Zobrazit plný text záznamu

Disruption of lipid rafts causes apoptotic cell death in HaCaT keratinocytes

Autor: Barbara Gajkowska, Robert Gniadecki, Bo Bang

Publikováno v: Experimental Dermatology. 14:266-272

Lipid rafts are cholesterol-enriched microdomains in plasma membranes. The functional activity of many membrane proteins, including death and growth factor receptors, depends on their insertion in lipid rafts. We have previously demonstrated the pres

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4654fa74fe527f6831c32635c0f491fe
https://doi.org/10.1111/j.0906-6705.2005.00283.x

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání